Jan‐Marcus Daniel

1.3k total citations
31 papers, 992 citations indexed

About

Jan‐Marcus Daniel is a scholar working on Molecular Biology, Cancer Research and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Jan‐Marcus Daniel has authored 31 papers receiving a total of 992 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Cancer Research and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Jan‐Marcus Daniel's work include Angiogenesis and VEGF in Cancer (6 papers), MicroRNA in disease regulation (4 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). Jan‐Marcus Daniel is often cited by papers focused on Angiogenesis and VEGF in Cancer (6 papers), MicroRNA in disease regulation (4 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). Jan‐Marcus Daniel collaborates with scholars based in Germany, United States and Norway. Jan‐Marcus Daniel's co-authors include Daniel Sedding, Jochen Dutzmann, Johann Bauersachs, Harald Tillmanns, Philipp Stieger, Denise Hilfiker‐Kleiner, Sandip M. Kanse, Ruediger C. Braun‐Dullaeus, Sönke Weinert and Klaus T. Preissner and has published in prestigious journals such as Nucleic Acids Research, Circulation and The Journal of Experimental Medicine.

In The Last Decade

Jan‐Marcus Daniel

30 papers receiving 982 citations

Peers

Countries citing papers authored by Jan‐Marcus Daniel

Since Specialization

Citations

This map shows the geographic impact of Jan‐Marcus Daniel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan‐Marcus Daniel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan‐Marcus Daniel more than expected).

Fields of papers citing papers by Jan‐Marcus Daniel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan‐Marcus Daniel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan‐Marcus Daniel. The network helps show where Jan‐Marcus Daniel may publish in the future.

Co-authorship network of co-authors of Jan‐Marcus Daniel

This figure shows the co-authorship network connecting the top 25 collaborators of Jan‐Marcus Daniel. A scholar is included among the top collaborators of Jan‐Marcus Daniel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan‐Marcus Daniel. Jan‐Marcus Daniel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Adventitial Fibroblasts Release Interleukin 6 After Vascular Injury and Induce Smooth Muscle Cell Proliferation and Neointima Formation 2025 ·Journal of the American Heart Association ·Jochen Dutzmann, Jan‐Marcus Daniel, (unknown), (unknown), (unknown), (unknown), Kevin Croce, Thomáš Herbst, Barbara Huibregtse, Felix Vogt, Stefan Offermanns, Johann Bauersachs, Daniel Sedding	0
2	Intermittent Fasting After ST-Segment–Elevation Myocardial Infarction Improves Left Ventricular Function: The Randomized Controlled INTERFAST-MI Trial 2024 ·Circulation Heart Failure ·Jochen Dutzmann, (unknown), Florian Kahles, Jan‐Marcus Daniel, Hubert Gufler, Walter A. Wohlgemuth, (unknown), Daniel Sedding	8
3	Effect of intermittent fasting after ST-elevation myocardial infarction on left ventricular function: study protocol of a pilot randomised controlled trial (INTERFAST-MI) 2022 ·BMJ Open ·Jochen Dutzmann, (unknown), (unknown), Jan‐Marcus Daniel, Hubert Gufler, Walter A. Wohlgemuth, Florian Kahles, Daniel Sedding	3
4	Empagliflozin prevents neointima formation by impairing smooth muscle cell proliferation and accelerating endothelial regeneration 2022 ·Frontiers in Cardiovascular Medicine ·Jochen Dutzmann, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Susanne Koch, Heiko Schenk, Jan‐Marcus Daniel, Johann Bauersachs, Daniel Sedding	11
5	13Vasorin controls smooth muscle cell proliferation by regulating EGFR activation 2018 ·Cardiovascular Research ·(unknown), (unknown), (unknown), Jochen Dutzmann, Jan‐Marcus Daniel, Johann Bauersachs, Daniel Sedding	2
6	The novel mineralocorticoid receptor antagonist finerenone attenuates neointima formation after vascular injury 2017 ·PLoS ONE ·Jochen Dutzmann, (unknown), (unknown), Jan‐Marcus Daniel, Kristina Sonnenschein, Andreas Schäfer, Peter Kolkhof, Johann Bauersachs, Daniel Sedding	42
7	Systemic application of sirolimus prevents neointima formation not via a direct anti-proliferative effect but via its anti-inflammatory properties 2017 ·International Journal of Cardiology ·Jan‐Marcus Daniel, Jochen Dutzmann, (unknown), Johann Bauersachs, Ruediger C. Braun‐Dullaeus, Daniel Sedding	14
8	Factor VII activating protease (FSAP) influences vascular remodeling in the mouse hind limb ischemia model. 2017 ·PubMed ·Joerg Herold, (unknown), Sawa Kostin, Jan‐Marcus Daniel, Alexander Francke, Saravanan Subramaniam, Ruediger C. Braun‐Dullaeus, Sandip M. Kanse	9
9	Factor VII‐activating protease deficiency promotes neointima formation by enhancing leukocyte accumulation 2016 ·Journal of Thrombosis and Haemostasis ·Jan‐Marcus Daniel, Christoph A. Reichel, (unknown), Jochen Dutzmann, Gabriele Zuchtriegel, Fritz Krombach, Joerg Herold, Johann Bauersachs, Daniel Sedding, Sandip M. Kanse	14
10	Emerging translational approaches to target STAT3 signalling and its impact on vascular disease 2015 ·Cardiovascular Research ·Jochen Dutzmann, Jan‐Marcus Daniel, Johann Bauersachs, Denise Hilfiker‐Kleiner, Daniel Sedding	80
11	DNA-dependent protein kinase (DNA-PK) permits vascular smooth muscle cell proliferation through phosphorylation of the orphan nuclear receptor NOR1 2015 ·Cardiovascular Research ·Senad Medunjanin, Jan‐Marcus Daniel, Sönke Weinert, Jochen Dutzmann, (unknown), (unknown), Dennis Bruemmer, Thilo Kähne, Michael Naumann, Daniel Sedding, Werner Zuschratter, Ruediger C. Braun‐Dullaeus	26
12	Comprehensive analysis of clinico-pathological data reveals heterogeneous relations between atherosclerosis and cancer 2014 ·Journal of Clinical Pathology ·Jan Budczies, Moritz von Winterfeld, Frederick Klauschen, (unknown), Jan‐Marcus Daniel, Arne Warth, Volker Endris, Carsten Denkert, Heriberto Pfeiffer, Wilko Weichert, Manfred Dietel, Daniel Wittschieber, Albrecht Stenzinger	13
13	Inhibition of miR-92a improves re-endothelialization and prevents neointima formation following vascular injury 2014 ·Cardiovascular Research ·Jan‐Marcus Daniel, Daniela Penzkofer, Rebecca Teske, Jochen Dutzmann, Armin Koch, (unknown), Angelika Bonauer, Reinier A. Boon, Ariane Fischer, Johann Bauersachs, Eva van Rooij, Stefanie Dimmeler, Daniel Sedding	117
14	Role of the Phosphatase PTEN in Early Vascular Remodeling 2013 ·PLoS ONE ·Daniel Sedding, (unknown), Andreas Mueller, Philipp Stieger, Jan‐Marcus Daniel, Dursun Gündüz, Soni Savai Pullamsetti, Holger Nef, (unknown), Christian Troidl, Christian W. Hamm, Ruediger C. Braun‐Dullaeus	21
15	Inhibition of STAT3 signaling prevents vascular smooth muscle cell proliferation and neointima formation 2012 ·Basic Research in Cardiology ·Jan‐Marcus Daniel, Jochen Dutzmann, (unknown), (unknown), Dursun Gündüz, Christian W. Hamm, Daniel Sedding	56
16	Abstract 20299: Depletion of Extracellular RNA Improves Survival after Myocardial Infarction Reducing Vascular Permeability, Edema Formation and Myocardial Tissue Damage 2010 ·Circulation ·Philipp Stieger, (unknown), Mathias Grebe, Jan‐Marcus Daniel, Klaus T. Preissner, Silvia Fischer, (unknown), Harald Tillmanns, Daniel Sedding	1
17	Circulating smooth muscle progenitor cells in arterial remodeling 2010 ·Journal of Molecular and Cellular Cardiology ·Jan‐Marcus Daniel, Daniel Sedding	46
18	The G534E polymorphism of the gene encoding the factor VII–activating protease is associated with cardiovascular risk due to increased neointima formation 2006 ·The Journal of Experimental Medicine ·Daniel Sedding, Jan‐Marcus Daniel, Lars Muhl, Karin Hersemeyer, (unknown), B. Kemkes‐Matthes, Ruediger C. Braun‐Dullaeus, Harald Tillmanns, Thomas Weimer, Klaus T. Preissner, Sandip M. Kanse	64
19	Factor VII activating protease (FSAP) inhibits neointima formation and the G511E polymorphism is associated with atherosclerosis due to a loss of this activity 2006 ·Vascular Pharmacology ·Daniel Sedding, Sandip M. Kanse, (unknown), Jan‐Marcus Daniel, Lars Muhl, Karin Hersemeyer, (unknown), B. Kemkes‐Matthes, Ruediger C. Braun‐Dullaeus, (unknown)	2
20	The p120ctn-binding partner Kaiso is a bi-modal DNA-binding protein that recognizes both a sequence-specific consensus and methylated CpG dinucleotides 2002 ·Nucleic Acids Research ·Jan‐Marcus Daniel	212

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact